PROSTATE CANCER FOUNDATION-FUNDED RESEARCH IDENTIFIES PROMISING PRECISION IMMUNOTHERAPY APPROACH FOR ADVANCED PROSTATE CANCER

Study defines a mechanism by which prostate cancer cells resist immunotherapy and a possible new approach to reprogram them in an aggressive form of advanced disease. LOS ANGELES, April 5, 2023 /PRNewswire/ — Although immunotherapies can successfully treat many types of cancer, they have…